Characterization of Dicaffeoylspermidine Derivatives from Wolfberry as Potent and Selective Inhibitors of Human Cytochrome P450 46A1 In vitro

Release Time:2024-09-03  Hits:

Indexed by: Journal Papers

Document Code: 371954

Date of Publication: 2023-01-01

Journal: CURRENT DRUG METABOLISM

Volume: 24

Issue: 2

Page Number: 124-130

ISSN: 1389-2002

Key Words: BINDING; CHOLESTEROL DEGRADATION; COMPLEX; CYP46A1 INHIBITION; ENZYME; FRUITS; LYCIUM-BARBARUM; PREDICTIONS; VORICONAZOLE

Prev One:Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases

Next One:Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronyltransferase (UGT) 1A1